Catalyst Calendar

Tue, Sep 1, 2026

1 updates

7:00 AM

Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

CHAPEL HILL, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”) announced today that Chris Giordano, President & Chief Executive Officer, will present at the 2026 Cantor Global Healthcare Conference on Wednesday,

tenaxthera.com

Sat, Aug 29, 2026

1 updates

TENX

8:22 AM

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026

In patients with a baseline 6MWD below the trial median of 333 meters, treatment with TNX-103 resulted in a 26.3-meter improvement compared to placebo (p = 0.0112) In the same patient population, TNX-103 produced a 47% reduction in NT-proBNP (p 0.0001) and a 4.9 mmHg reduction in RVSP (p = 0.009)

Presentation / Abstract • Phase 3ESC Congress late-breaking presentation Sat, Aug 29, 2026tenaxthera.com